Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study

OBJECTIVE: To describe patients’ perspectives on the burden associated with methotrexate (MTX) or tumor necrosis factor inhibitor (TNFi) use in psoriatic arthritis (PsA) and rheumatoid arthritis (RA). METHODS: Between May 2019 and March 2020, patients receiving MTX and/or a TNFi for either PsA or RA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogdie, Alexis, Shaw, Yomei, Almonte, Michele, Maksabedian Hernandez, Ervant J., Stolshek, Bradley, Michaud, Kaleb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100692/
https://www.ncbi.nlm.nih.gov/pubmed/36762609
http://dx.doi.org/10.1002/acr2.11530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100692/
https://www.ncbi.nlm.nih.gov/pubmed/36762609
http://dx.doi.org/10.1002/acr2.11530

Ejemplares similares